StockData
Rapport Therapeutics, Inc. logo

Rapport Therapeutics, Inc. (RAPP) stock

RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$23.76−1.06 (-4.27%)

Close on Nov 17, 2026Market cap $1.14BP/E –Yield –

Rapport Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Rapport Therapeutics's price to book ratio was 3.1× on Nov 11, 2026, against 2.8× a year earlier. Over the last 2 years it ranged from 1.1× to 5.5×, with a median of 2.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.1×+0.2
2025Dec 31, 20252.8×+0.8
2024Dec 31, 20242.0×–

More Rapport Therapeutics figures

See a number that looks wrong?